A Statin a Day to Keep the Doctor Away? Comparing Aspirin and Statins for Primary Prevention of Cardiovascular Disease
Authors:
- 23 June 2014
- journal article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 48 (9) , 1238-1241
Abstract
For the primary prevention of cardiovascular (CV) disease, aspirin reduces the risk for major vascular events by approximately 15% to 20% with an absolute reduction of approximately 0.1%. Major bleeding occurs at an excess of approximately 2 cases per 1000 patient-years with aspirin therapy. For primary prevention, statin therapy has been shown to reduce the risk of CV events by approximately 30% to 40% with an absolute reduction of 1% to 2%. Rhabdomyolysis is rare, with an incidence of 3.4 cases per 100 000 patient-years. Compared with aspirin, statins have a more favorable risk-to-benefit profile for primary prevention.Keywords
This publication has 15 references indexed in Scilit:
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- Should people at low risk of cardiovascular disease take a statin?BMJ, 2013
- Association of Aspirin Use With Major Bleeding in Patients With and Without DiabetesJAMA, 2012
- Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular DiseaseThe American Journal of Medicine, 2011
- Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitusThrombosis and Haemostasis, 2010
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Meta-Analysis of Data from the Six Primary Prevention Trials of Cardiovascular Events Using AspirinThe American Journal of Cardiology, 2006
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006